Hybrid treatment of fibroadipose vascular anomaly: A case report
Stillo Francesco,
Ruggiero Federica,
De Fiores Antonio,
Compagna Rita,
Amato Bruno
Affiliations
Stillo Francesco
Vascular Malformation Unit, Department of Surgery, Istituto, Clinica Guarnieri, Via Tor de’ Schiavi, 139, 00172, Rome (RM), Italy
Ruggiero Federica
Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Vascular Surgery Unit, University of Rome La Sapienza, Via di Grottarossa 1035/1039, 00189Rome, Italy
De Fiores Antonio
Vascular Malformation Unit, Department of Surgery, Istituto, Clinica Guarnieri, Via Tor de’ Schiavi, 139, 00172, Rome (RM), Italy
Compagna Rita
Department of Public Health, University of Naples “Federico II”, via Sergio Pansini, 5 – 80131, Naples, Italy
Amato Bruno
Department of Public Health, University of Naples “Federico II”, via Sergio Pansini, 5 – 80131, Naples, Italy
First identified in 2014, fibroadipose vascular anomaly (FAVA) is a very rare type of venous and lymphatic malformation. Marked by tough fibrofatty tissue in the extremities overtaking portions of the muscles, it is associated with constant pain and contracture of the affected extremity. There is a paucity of literature, and no guidelines on treatment procedure are available. This case highlights the role of hybrid treatment with primary ethanol percutaneous ethanol embolization and additional surgery for radicality in excision of FAVA lesions.
